Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survivalH Artee Luchman, Owen D M Stechishin, Stephanie A Nguyen, et al.
Journal of Neuropathology and Experimental Neurology|February 7, 2002
Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma"Hikaru Sasaki, Magdalena C Zlatescu, Rebecca A Betensky, et al.
Neuro-Oncology|April 15, 2010
Sensitivity to temozolomide in brain tumor initiating cellsMichael D Blough, Morgan R Westgate, Desiree Beauchamp, et al.
The Oncologist|February 16, 2006
Changing paradigms--an update on the multidisciplinary management of malignant gliomaRoger Stupp, Monika E Hegi, Martin J van den Bent, et al.
Epilepsy Research|February 15, 2011
Do epileptic seizures predict outcome in patients with oligodendroglioma?Seyed M Mirsattari, Jaron J R Chong, Robert R Hammond, et al.
Neuro-Oncology|December 25, 2012
On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cellsOwen D Stechishin, H Artee Luchman, Yibing Ruan, et al.
Cancer & Metabolism|April 6, 2018
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent mannerPavithra Viswanath, Marina Radoul, Jose Luis Izquierdo-Garcia, et al.
Pageof 9